Clinical Trial Details

Randomized Phase III Study of Second-Line Chemotherapy with or without Panitumumab for KRAS Wild Type, Locally Advanced or Metastatic Pancreatic Adenocarcinoma

IRB Protocol Number
S2433

Clinical Trial Categories

  • Pancreas/Billiary
Contact
Clinical Trials at 910-715-2200

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.